Search clinical trials for: Phosphodiesterase Type 5 Inhibitors
Total 119125 results
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyTerminatedRenal Cell Carcinoma | Metastases, Neoplasm | Neuroendocrine Tumors | Carcinoma, Non-small Cell LungFrance, United States
-
Eli Lilly and CompanyNippon Shinyaku Co., Ltd.Completed
-
Chromaderm, Inc.Completed
-
Eli Lilly and CompanyBerry Consultants; United BioSource, LLC; Tessella Inc.CompletedDiabetes Mellitus, Type 2United States, Korea, Republic of, Russian Federation, Puerto Rico, Romania, Spain, Taiwan, Mexico, France, Germany, India, Canada, Poland
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerChina
-
Eli Lilly and CompanyCompletedErectile DysfunctionChina
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedErectile DysfunctionGermany, Spain, Italy, Greece, Poland
-
Eli Lilly and CompanyCompletedBenign Prostatic HyperplasiaKorea, Republic of
-
Eli Lilly and CompanyCompletedErectile DysfunctionGermany, Spain, United States, Australia, Brazil, Italy, Mexico, Puerto Rico, United Kingdom
-
Eli Lilly and CompanyTerminatedSmall Cell Lung Cancer | SCLC | Carcinoma, Small CellNetherlands, Belgium
-
Eli Lilly and CompanyICOS CorporationCompletedBenign Prostatic HyperplasiaUnited States, Greece, Portugal
-
Eli Lilly and CompanyCompletedBreast Cancer | Breast Neoplasms, Male | Carcinoma, DuctalUnited States
-
Eli Lilly and CompanyCompletedPleural NeoplasmsUnited States
-
Eli Lilly and CompanyICOS CorporationCompletedErectile Dysfunction | ImpotenceFinland
-
Eli Lilly and CompanyICOS CorporationCompletedErectile DysfunctionUnited States
-
Eli Lilly and CompanyICOS CorporationCompletedErectile Dysfunction | Spinal Cord InjuriesUnited States
-
Eli Lilly and CompanyICOS CorporationCompletedImpotenceKorea, Republic of
-
Eli Lilly and CompanyICOS CorporationCompleted
-
Eli Lilly and CompanyICOS CorporationCompleted
-
Eli Lilly and CompanyICOS CorporationCompleted
-
Eli Lilly and CompanyICOS CorporationCompleted
-
Eli Lilly and CompanyICOS CorporationCompleted
-
Eli Lilly and CompanyICOS CorporationCompleted
-
Eli Lilly and CompanyCompletedBiliary Tract CarcinomaKorea, Republic of
-
Roswell Park Cancer InstitutePfizerWithdrawnRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Blasts 5 Percent or More of Bone Marrow Nucleated Cells | CD22 Positive | Allogeneic Hematopoietic Stem Cell Transplantation Recipient | Blasts 5 Percent or More of Peripheral Blood White Cells | Lymphoblasts... and other conditionsUnited States
-
Yuni Eka AnggrainiGadjah Mada UniversityNot yet recruiting
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Leukemia Cutis | Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLLUnited States
-
SCRI Development Innovations, LLCGlaxoSmithKlineTerminatedHER2 Positive Esophagogastric CancerUnited States
-
Federal University of São PauloUnknown
-
QualissimaCompletedSchizophrenia, Undifferentiated TypeFrance
-
GH Research Ireland LimitedRecruiting
-
National Institute of Public Health, CambodiaEmory University; World Vision International; World Vision, Hong Kong; World Vision...CompletedUnderweight Children Aged 6-23 Month Old (WAZ < -1)Cambodia
-
Astellas Pharma IncCompletedCandidiasis, OralSouth Africa, Brazil, Peru
-
Eleison Pharmaceuticals LLC.RecruitingMetastatic Pancreatic AdenocarcinomaUnited States
-
Luye Pharma Group Ltd.CompletedAdvanced Solid TumorChina
-
Peking Union Medical College HospitalOrigiMedRecruitingQuality of Life | Objective Response Rate | Overall Survival | Progression-free Survival | Disease Control Rate | Duration of Response | Five-year Survival RateChina
-
OrthoSpace Ltd.TerminatedFull- Thickness Massive RCT (MRCT) of at Least 5 cm in Diameter Including Fatty Infiltration Grade III or IVItaly
-
National Institute on Drug Abuse (NIDA)Cincinnati MDRUCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmUnited States
-
University of CopenhagenHospital - and gynaecological out-patient clinics in Central Region Denmark; Hospital - and gynaecological out-patient clinics in Region Zealand and other collaboratorsCompletedCervical Intraepithelial NeoplasiaDenmark
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Seoul National University HospitalUnknown
-
Icahn School of Medicine at Mount SinaiCompletedProstatic Neoplasms | Prostate Cancer | Prostate NeoplasmsUnited States